Rx only · Injection, Solution · Subcutaneous
Adalimumab-Aqvh
Brands: Yusimry · Adalimumab
2 ACTIVE SUPPLIERS - US
openFDA · updated weekly
US4 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
$604.153
Latest avg · Oct 29, 2025
+0%
Since May 21, 2025
2
Active US suppliers
100%